Get startedLog in
    Picture of Akums Drugs and Pharmaceuticals logo

    AKUMS — Akums Drugs and Pharmaceuticals Cashflow Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Akums Drugs and Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2021
    March 31st
    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    2025
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:PROSPECTUSPROSPECTUSPROSPECTUSPROSPECTUSARS
    Standards:
    IAS
    IAS
    IAS
    IAS
    IAS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line1,723-1,9321,503-4533,453
    Depreciation
    Non-Cash Items7525,3674494,305143
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-1,862-4,064-1,314-129-478
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities1,3113191,7664,9794,652
    Capital Expenditures-828-2,576-3,288-3,114-2,723
    Purchase of Fixed Assets
    Other Investing Cash Flow Items-266228241-190-2,755
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-1,094-2,348-3,047-3,304-5,478
    Financing Cash Flow Items-50.2-89.1-404-434-345
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-9152,3601,245-1,080728
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-697331-35.3594-98.6